Abingworth LLP Personalis, Inc. Transaction History

Abingworth LLP

  • $301 Million
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Mar 01, 2021
SELL
$21.84 - $44.0 $97.5 Million - $196 Million
-4,462,452 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$13.63 - $24.12 $13.5 Million - $23.8 Million
-986,842 Reduced 18.11%
4,462,452 $96.7 Million
Q2 2019

Aug 14, 2019
BUY
$27.0 - $30.25 $147 Million - $165 Million
5,449,294 New
5,449,294 $148 Million

Others Institutions Holding PSNL

# of Institutions
76
Shares Held
23.1M
Call Options Held
27.5K
Put Options Held
0
View Full List

About Personalis, Inc.

PSNL Quotes by TradingView
  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $230M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Abingworth LLP Portfolio

Follow Abingworth LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abingworth LLP, based on Form 13F filings with the SEC.

News

Stay updated on Abingworth LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email